Grafton Optical introduces QuickSee

The handheld autorefractor from PlenOptika combines open view binocular design with wavefront aberrometry and dynamic measurements

Looking through Grafton QuickSee

Grafton Optical has launched the QuickSee handheld autorefractor from PlenOptika.

The device combines open view binocular design, wavefront aberrometry, and dynamic measurements to produce clinically accurate autorefraction measurements.

As the QuickSee device is handheld, it can be used both in clinics and for field use, making it suitable for working with patients with mobility issues. The device can also be used indoors or outdoors, and in most light settings, as dark eye cups isolate the patient’s eyes from ambient light.

Launching the device in the UK and Ireland, David Thickens, Grafton Optical’s CEO, said: “This device is invaluable for quickly capturing accurate refraction information from a variety of patients aged five and over; from children, to the elderly and infirm with mobility issues.”

Thickens highlighted the applications of the device for domiciliary and care home use, as well as “busy optical practices and ophthalmology departments."

The company suggested the technology is as accurate as clinical desktop autorefractors and demonstrates a high level of agreement with subjective refraction (<= 0.25 D: 60-70% of patients and <= 0.5 D: 80-90% of patients).

Patients look through QuickSee like they would look through binoculars, at a target at least three to six metres away.

The company suggested that by using wavefront aberrometry to measure refractive error, the QuickSee captures information that is unavailable to traditional autorefractors, enhancing the eye care professional’s assessment of what correction is needed. The open view binocular design also reduces device-induced myopia and accommodation.

Introducing the device, Grafton Optical said: “Dynamic measurements enable QuickSee to provide highly confident measurements. Patients’ eyes are relaxed and allowed to function normally, and they don’t require cycloplegia, for precise measurements of refractive error in the eyes’ natural state.”

The device can be used for up to eight hours on battery and also operates while tethered for charging. Users can perform measurements after 30 minutes of training.

Reflecting on the launch, Thickens told OT: “We have had a very positive response to this device since launching and are excited to be able to introduce this innovative new technology to our customers.”